KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Asset Writedowns and Impairment (2016 - 2026)

Bristol Myers Squibb has reported Asset Writedowns and Impairment over the past 17 years, most recently at $412.0 million for Q1 2026.

  • Quarterly Asset Writedowns and Impairment rose 8140.0% to $412.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Mar 2026, down 49.28% year-over-year, with the annual reading at $1.1 billion for FY2025, 62.94% down from the prior year.
  • Asset Writedowns and Impairment was $412.0 million for Q1 2026 at Bristol Myers Squibb, down from $584.0 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $2.0 billion in Q4 2024 and troughed at $1.0 million in Q1 2024.
  • The 5-year median for Asset Writedowns and Impairment is $61.0 million (2022), against an average of $288.6 million.
  • Year-over-year, Asset Writedowns and Impairment plummeted 95.0% in 2024 and then soared 8140.0% in 2026.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $35.0 million in 2022, then fell by 17.14% to $29.0 million in 2023, then soared by 6634.48% to $2.0 billion in 2024, then plummeted by 70.1% to $584.0 million in 2025, then decreased by 29.45% to $412.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Asset Writedowns and Impairment are $412.0 million (Q1 2026), $584.0 million (Q4 2025), and $196.0 million (Q3 2025).